Anti-GRAMD4 antibodies are used in the immunodetection of the protein GRAM domain containing 4. In humans, the canonical protein has a reported length of 578 amino acid residues and a mass of 66.4 kDa. Its subcellular localization is in the mitochondria and ER. Up to 2 different isoforms have been reported for this protein. It is reported to be expressed in the lung and in primary lung squamous cell carcinoma (LSCC). GRAMD4 is reported to play a role as a mediator of E2F1-induced apoptosis in the absence of p53/TP53. Synonyms for this target antigen include GRAM domain-containing protein 4, death-inducing-protein, and DIP. GRAMD4 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some GRAMD4 antibodies may have been used in research and have associated citations. Immunofluorescence is a widely used application for these antibodies. ELISA, Flow Cytometry, and Immunocytochemistry are also common applications.